Log in to search using one of your social media accounts:

 

Sirion Biotech to Attend ESGCT XXV Anniversary Congress
Sirion Biotech has announced it will be attending the ESGCT XXV Anniversary Congress, in collaboration with the German Society for Gene Therapy DG-GT. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 21, 2017 Category: Pharmaceuticals Source Type: news

Unique gene therapy prevents, reverses multiple sclerosis in animal model
(University of Florida) Multiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops the disease's immune response in mouse models, University of Florida Health researchers have found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 21, 2017 Category: International Medicine & Public Health Source Type: news

Mesothelioma Clinical Trials Involve Gene Therapy
Treatment options for malignant mesothelioma may soon include customized gene therapy, according to thoracic surgeon and scientist Dr. Prasad Adusumilli at Memorial Sloan Kettering Cancer Center in New York. Gene therapy involves a laboratory reprogramming of a patient’s own T cells, which are a type of white blood cell, to recognize and destroy the cancer. The U.S. Food and Drug Administration (FDA) recently approved the first gene therapy specifically for pediatric leukemia, signaling the start of a new approach to cancer treatment in this country. The newly approved treatment is also known as chimeric antigen rece...
Source: Asbestos and Mesothelioma News - September 19, 2017 Category: Environmental Health Authors: Matt Mauney Tags: CAR T cell therapy checkpoint blockade chimeric antigen receptor T cell therapy Dr. Andy Haas Dr. Prasad Adusumilli Dr. Scott Gottlieb FDA Commissioner gene therapy cancer gene therapy for mesothelioma immunotherapy clinical trial mali Source Type: news

Gene therapy firm Dimension would keep Cambridge office under latest buyout offer
A bidding war between California-based Ultragenyx Pharmaceutical against Regenxbio of Maryland could determine the fate of Dimension's headquarters and employees. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 18, 2017 Category: American Health Authors: Max Stendahl Source Type: news

New study shows promise of gene therapy to treat alcoholism
(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers used gene transfer to block the expression of one of the two main enzymes that break down alcohol in the liver, leading to the accumulation in liver cells of acetaldehyde, a metabolic byproduct of ethanol. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2017 Category: International Medicine & Public Health Source Type: news

New assay leads to step toward gene therapy for deaf patients
(Oregon State University) Scientists at have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2017 Category: International Medicine & Public Health Source Type: news

New Gene-Therapy Treatments Will Carry Whopping Price Tags
Kymriah, approved recently by the F.D.A., with a $475,000 price tag, is first of a coming wave of treatments whose expected prices have alarmed economists, scientists and insurers. (Source: NYT Health)
Source: NYT Health - September 11, 2017 Category: Consumer Health News Authors: GINA KOLATA Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Genetic Engineering Prices (Fares, Fees and Rates) Source Type: news

Future Cancer Treatment in New Cancer Gene Therapy
1 day ago ... ... including lymphoma and other forms of leukemia," Len Lichtenfeld, deputy chief medical officer for the American Cancer Society, tells AARP. (Source: AARP.org News)
Source: AARP.org News - September 10, 2017 Category: American Health Source Type: news

Researchers Find Genes Linked to Preterm Birth
They also found that low selenium may play a role in early delivery, but these findings need to be replicated Source: HealthDay Related MedlinePlus Pages: Dietary Supplements, Genes and Gene Therapy, Preterm Labor (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 6, 2017 Category: Consumer Health News Source Type: news

Morning Rounds: Flooding health concerns, Harvey's emotional toll
Dr. David Agus joins "CBS This Morning: Saturday" from Los Angeles to discuss some of the health concerns for survivors of Hurricane Harvey, a potential breakthrough in the way we fight cardiovascular disease and a new FDA-approved gene therapy in the U.S. that treats children and young adults with leukemia. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 2, 2017 Category: Consumer Health News Source Type: news

Lexington biotech plots $86M IPO as key gene therapy trial nears
A Lexington biotech developing gene therapy treatments for rare eye diseases has announced plans to raise up to $86 million in an initial public offering. Nightstar Therapeutics, a 23-employee company with a 3,300 square foot office in Lexington and a smaller corporate headquarters in London, said in a federal filing on Thursday that it had applied to list its shares on the Nasdaq Global Market under the ticker “NITE.” The biotech and healthcar e IPO market has picked up this year after a slow… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 1, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

A parent ’s guide to clinical trials
Children with life-threatening conditions, such as cancer, are often candidates for clinical trials. What are they? Which factors should parents weigh in determining whether enrolling in one is a good option for their child? Dr. Steven DuBois, director of the Advancing Childhood Cancer Therapies Clinic at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, answers questions about clinical trials. What are clinical trials? Why are they important? Clinical trials are systematic, scientific investigations of new drugs or therapies for a specific disease. Through clinical trials, we have taken many fatal ped...
Source: Thrive, Children's Hospital Boston - September 1, 2017 Category: Pediatrics Authors: Irene Sege Tags: Ask the Expert Research and Innovation clinical trial Dana-Farber/Boston Children's Cancer and Blood Disorders Center Dr. Steven DuBois Source Type: news

Monthly News Roundup - August 2017
Kymriah from Novartis Approved as First U.S. CAR-T Cell Therapy History was made this month as the U.S. Food and Drug Administration (FDA) approved the first U.S. cell-based gene therapy known collectively as chimeric antigen receptor (CAR)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 31, 2017 Category: Pharmaceuticals Source Type: news

Children ’s Mercy patients benefit from first FDA-approved cancer gene therapy
Children's Mercy patients participated in a clinical trial of Novartis' new cancer treatment. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 31, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

FDA approves breakthrough CAR-T therapy for leukemia
With FDA approval, breakthrough CAR-T therapy for cancer becomes the first approved gene therapy treatment in the U.S. It reprograms the body's own immune system to attack a deadly type of blood cancer and has been effective in treating children and young adults with leukemia. Cancer expert Dr. David Agus joins "CBS This Morning" to discuss who's eligible and the risks of treatment. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 31, 2017 Category: Consumer Health News Source Type: news

US clears breakthrough gene therapy for childhood leukemia
The U.S. has cleared a breakthrough cancer treatment that uses gene therapy to turn patients' own blood cells into assassins that attack childhood leukemia (Source: ABC News: Health)
Source: ABC News: Health - August 31, 2017 Category: Consumer Health News Tags: Health Source Type: news

First Gene Therapy Approved in U.S.
Title: First Gene Therapy Approved in U.S.Category: Health NewsCreated: 8/30/2017 12:00:00 AMLast Editorial Review: 8/31/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 31, 2017 Category: Cancer & Oncology Source Type: news

Landmark moment for science as the FDA approves a gene therapy for the first time
(Boston Children's Hospital) Dana-Farber/Boston Children's recently participated in a similar clinical trial of CAR T-cells that evaluated the efficacy of CAR T-cell therapy in treating relapsed or treatment-resistant B-cell ALL.'The lessons learned from the clinical trials of CAR T-cell operations will assist us in being able to provide to the larger population,' says Colleen Dansereau, MSN, RN and CPN, who is director of clinical research nursing and gene therapy program manager at Dana-Farber/Boston Children's. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2017 Category: Cancer & Oncology Source Type: news

Novartis gene therapy approval signals new cancer treatment era
(Reuters) - Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers. (Source: Reuters: Health)
Source: Reuters: Health - August 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves "brand new way" to treat leukemia
The Food and Drug Administration on Wednesday approved the first gene therapy to fight leukemia. The treatment turns a patient's blood cells into cancer killers. Jim Axelrod has more. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 31, 2017 Category: Consumer Health News Source Type: news

FDA Approves First Gene Therapy in the United States
Kymriah approved for patients up to 25 years of age with refractory or relapsed B - cell precursor ALL (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 31, 2017 Category: Cancer & Oncology Tags: Oncology, Pathology, Pharmacy, Institutional, Source Type: news

First Gene Therapy Approved in U.S. (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The FDA on Wednesday approved tisagenlecleucel (Kymriah) for patients up to age 25 years with B cell precursor acute lymphoblastic leukemia that has relapsed or not responded … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 30, 2017 Category: Primary Care Source Type: news

FDA approves first 'living drug' that uses gene therapy to fight cancer
The Food and Drug Administration has approved a new type of cancer drug that uses gene therapy to bolster a patient's own immune system cells. More such "living drugs" are expected to follow. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - August 30, 2017 Category: Science Authors: Melissa Healy Source Type: news

Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’
The Food and Drug Administration has approved a new type of cancer drug that uses gene therapy to bolster a patient's own immune system cells. More such "living drugs" are expected to follow. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - August 30, 2017 Category: Science Authors: Melissa Healy Source Type: news

HealthWatch: A New Gene Therapy For Leukemia; A Study On Carbohydrates
This study does not mean you can now eat a ton of butter and steak without worry, but you probably don’t need to feel guilty about eating some fat. In terms of carbohydrates, the study did not distinguish between refined carbs and complex carbs, so further study is needed. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 30, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Cancer Research Dr. Mallika Marshall Leukemia Source Type: news

Cancer breakthrough: Scientists hail gene therapy treatment which KILLS cancer cells
THE US has approved a cancer treatment which genetically alters cells. (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2017 Category: Consumer Health News Source Type: news

First Gene Therapy Approved in U.S.
For certain people with blood/bone marrow cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 30, 2017 Category: Cancer & Oncology Tags: Oncology, Pharmacy, FDA Approvals, Source Type: news

FDA clears first gene-altering therapy — ‘ a living drug ’ — for childhood leukemia
The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' genetically altered immune cells to fight the disease. It is the first gene therapy to be cleared in the United States — a “historic” action, the agency said -- and one with major ramifications for patients with […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’ (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA clears first gene-altering therapy — ‘ a living drug ’ — for childhood leukemia
The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' genetically altered immune cells to fight the disease. It is the first gene therapy to be cleared in the United States — a “historic” action, the agency said — and one with major ramifications for patients with […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’ (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA approves first gene therapy to treat leukemia
CAR-T cell treatment is called "a brand new way of treating cancer" (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 30, 2017 Category: Consumer Health News Source Type: news

FDA Approves Kymriah (tisagenlecleucel) CAR-T Gene Therapy for Acute Lymphoblastic Leukemia
August 30, 2017 -- The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 30, 2017 Category: Drugs & Pharmacology Source Type: news

US clears first gene therapy for childhood leukemia
The CAR-T cell treatment developed by Novartis Pharmaceuticals and the University of Pennsylvania is the first type of gene therapy to hit the U.S. market. (Source: the Mail online | Health)
Source: the Mail online | Health - August 30, 2017 Category: Consumer Health News Source Type: news

Novartis gene therapy approval signals new cancer treatment era
(Reuters) - Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers. (Source: Reuters: Health)
Source: Reuters: Health - August 30, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA announces first US gene therapy approval for cancer treatment
The US Food and Drug Administration approved a new leukemia treatment, which the agency considers the first gene therapy it has cleared to hit the market in the United States. (Source: CNN.com - Health)
Source: CNN.com - Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA approves first US gene therapy treatment for cancer
The US Food and Drug Administration approved a new leukemia treatment, which the agency considers the first gene therapy it has cleared to hit the market in the United States. (Source: CNN.com - Health)
Source: CNN.com - Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA OKs 1st Gene Therapy for Use in U.S.
It transforms a patient's immune system cells to fight a form of leukemia (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 30, 2017 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Research, News, Source Type: news

FDA Approves CAR T-Cell Therapy for Leukemia
(MedPage Today) --'First gene therapy available in the United States,'says agency (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 30, 2017 Category: American Health Source Type: news

FDA approves first-of-its-kind ‘ living drug ’ for childhood leukemia
The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' own genetically altered immune cells to fight the disease. It is the first gene therapy to be allowed in the United States — a “historic” approval, the agency said. The decision clears the Novartis drug, called Kymriah, […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’ (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA OKs 1st Gene Therapy for Use in U.S.
It transforms a patient's immune system cells to fight a form of leukemia Source: HealthDay Related MedlinePlus Pages: Acute Lymphocytic Leukemia, Genes and Gene Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 30, 2017 Category: Consumer Health News Source Type: news

Novartis approval for gene therapy signals new cancer treatment era
(Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday gave a green light to Novartis AG's leukemia treatment, marking the first time that a highly anticipated new type of potent gene-modifying immunotherapy has gained approval in the United States. (Source: Reuters: Health)
Source: Reuters: Health - August 30, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

First gene therapy coming to U.S. after FDA approval
The U.S. Food and Drug Administration announced today it is making the first gene therapy available in the United States to treat acute lymphoblastic leukemia. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 30, 2017 Category: Consumer Health News Source Type: news

FDA approval brings first gene therapy to the United States
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA approved Kymriah (tisagenlecleucel) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL). (Source: World Pharma News)
Source: World Pharma News - August 30, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA backs Novartis cancer gene therapy
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 30, 2017 Category: Pharmaceuticals Source Type: news

FDA approval brings first gene therapy to the United States
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 30, 2017 Category: American Health Source Type: news

First Gene Therapy Kymriah (tisagenlecleucel) Approved in U.S.
WEDNESDAY, Aug. 30, 2017 -- The U.S. Food and Drug Administration on Wednesday approved the first gene therapy in the United States, to treat children and young adults with a particularly tough type of leukemia. Kymriah (tisagenlecleucel) is for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 30, 2017 Category: General Medicine Source Type: news

FDA Approves First Gene Therapy, Kymriah, for Use in U.S.
WEDNESDAY, Aug. 30, 2017 -- The U.S. Food and Drug Administration broke new ground in cancer care Wednesday by approving the first gene therapy for patients in the United States. Kymriah (tisagenlecleucel) genetically tweaks a patient's own immune... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 30, 2017 Category: General Medicine Source Type: news

UChicago Medicine working to offer breakthrough CAR T-cell gene therapy approved by FDA
(University of Chicago Medical Center) The University of Chicago Medicine is one of a limited number of US sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the US Food and Drug Administration. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 30, 2017 Category: Cancer & Oncology Source Type: news

First-ever cancer gene therapy approved by FDA
(Alliance for Cancer Gene Therapy) Today's FDA approval of the first-ever CAR T gene therapy for cancer, kymriah, and its orgins. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 30, 2017 Category: International Medicine & Public Health Source Type: news

FDA OKs 1st Gene Therapy for Use in U.S.
It transforms a patient's immune system cells to fight a form of leukemia (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - August 30, 2017 Category: Cancer & Oncology Source Type: news

Gene Therapy for the Eyes: Ophthalmology Times
(MedPage Today) -- Also, key characteristics of subretinal hyperreflective material (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 29, 2017 Category: American Health Source Type: news